Pharmacogenetics and immunosuppressive drugs in solid organ transplantation

被引：0
|
作者：
Teun van Gelder
Ron H. van Schaik
Dennis A. Hesselink
机构：
[1] Erasmus MC,Department of Hospital Pharmacy
[2] University Medical Center Rotterdam,Department of Clinical Chemistry
[3] Erasmus MC,Department of Internal Medicine
[4] University Medical Center Rotterdam,undefined
[5] Erasmus MC,undefined
[6] University Medical Center Rotterdam,undefined
来源：
Nature Reviews Nephrology | 2014年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The prediction made 15 years ago that pharmacogenetics would revolutionize pharmacotherapy has not materializedFor several immunosuppressive drugs, studies show significant associations between polymorphisms in genes encoding metabolizing enzymes and pharmacokinetic dataStudies showing a clinical benefit if immunosuppressive drug dose is based on pharmacogenetic data are lackingEfficient therapeutic drug monitoring can rapidly correct for deviations in drug exposureTreatment algorithms that include polymorphisms in genes encoding pharmacodynamic parameters, drug transporter proteins, and predictors of toxicity will provide additional benefit
引用
收藏
页码：725 / 731
页数：6
相关论文
共 50 条
  • [21] Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation
    Brunet, Merce
    Shipkova, Maria
    van Gelder, Teun
    Wieland, Eberhard
    Sommerer, Claudia
    Budde, Klemens
    Haufroid, Vincent
    Christians, Uwe
    Lopez-Hoyos, Marcos
    Barten, Markus J.
    Bergan, Stein
    Picard, Nicolas
    Millan Lopez, Olga
    Marquet, Pierre
    Hesselink, Dennis A.
    Noceti, Ofelia
    Pawinski, Tomasz
    Wallemacq, Pierre
    Oellerich, Michael
    THERAPEUTIC DRUG MONITORING, 2016, 38 : S1 - S20
  • [22] Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation
    Tron, Camille
    Lemaitre, Florian
    Verstuyft, Celine
    Petitcollin, Antoine
    Verdier, Marie-Clemence
    Bellissant, Eric
    CLINICAL PHARMACOKINETICS, 2019, 58 (05) : 593 - 613
  • [23] Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation
    Camille Tron
    Florian Lemaitre
    Céline Verstuyft
    Antoine Petitcollin
    Marie-Clémence Verdier
    Eric Bellissant
    Clinical Pharmacokinetics, 2019, 58 : 593 - 613
  • [24] Pharmacology of Immunosuppressive Medications in Solid Organ Transplantation
    Schonder, Kristine S.
    CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2011, 23 (03) : 405 - +
  • [25] Complications of Immunosuppressive Therapy in Solid Organ Transplantation
    Katabathina, Venkata
    Menias, Christine O.
    Pickhardt, Perry
    Lubner, Meghan
    Prasad, Srinivasa R.
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2016, 54 (02) : 303 - +
  • [26] Statins in solid organ transplantation: Is there an immunosuppressive effect?
    Kobashigawa, JA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (07) : 1013 - 1018
  • [27] Immunosuppressive drugs and associated complications in abdominal organ transplantation
    Olson, Jody C.
    CURRENT OPINION IN CRITICAL CARE, 2022, 28 (02) : 208 - 215
  • [28] Immunosuppressive drugs and the risk of cancer after organ transplantation
    Dantal, J
    Soulillou, JP
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (13): : 1371 - 1373
  • [29] Use of methylxanthines (MeXa) as immunosuppressive drugs for organ transplantation
    Lin, Y
    Schonharting, M
    Goebels, J
    Rutgeerts, O
    Mikhalsky, D
    Waer, M
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 1279 - 1279
  • [30] The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation
    Hesselink, Dennis A.
    Bouamar, Rachida
    Elens, Laure
    van Schaik, Ron H. N.
    van Gelder, Teun
    CLINICAL PHARMACOKINETICS, 2014, 53 (02) : 123 - 139
12345